Publications by authors named "Abdel Aziz Selly-Ngaloumo"
This study aimed to assess the global prevalence of occult hepatitis B in blood donors. We searched PubMed, Web of Science, Global Index Medicus, and Excerpta Medica Database. Study selection and data extraction were performed by at least two independent investigators.
View Article and Find Full Text PDFEffectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
BMC Infect Dis
February 2022
Background: Many studies have reported high efficacy and safety of artesunate-amodiaquine (AS-AQ) and artemether-lumefantrine (AL) when administered under direct observation in Cameroon. There is paucity of data to support their continuous use in home-based treatment of uncomplicated Plasmodium falciparum malaria in Cameroon. Hence, this study aimed to assess the effectiveness and safety of AS-AQ versus AL for home-based treatment of uncomplicated P.
View Article and Find Full Text PDFHepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.
PLoS One
February 2022
Introduction: Africa denotes unique facies for hepatocellular carcinoma (HCC) characterized by a conjunction of low sensitization, restricted access to diagnosis and treatment and associated with the highest incidence and mortality in the world. We investigated whether hepatitis B (HBV), C (HCV) and D (VHD) viruses were etiological agents of HCC in Africa.
Methods: Relevant articles were searched in PubMed, Web of Science, African Index Medicus, and African Journal Online databases, as well as manual searches in relevant reviews and included articles.
Article Synopsis
- Hepatitis B virus (HBV) is a major global health issue, impacting around 2 billion people and causing about 1 million deaths annually, with healthcare workers (HCWs) at high risk due to potential exposure to infected blood.
- This study aims to assess the global prevalence of HBV serological markers among HCWs by analyzing relevant research published between 1970 and 2019, including a total of 227 studies from 71 countries.
- The meta-analysis revealed a pooled prevalence of current HBV infection (2.3%), with very low rates for HBeAg (0.2%) among the HCW population, highlighting the importance of monitoring and improving HBV control strategies in healthcare settings.